Last reviewed · How we verify
Phennin (phenyl acetylsalicylate)
Phennin (generic name: phenyl acetylsalicylate) is a drug. It is currently in unknown development.
Phennin works by inhibiting the production of prostaglandins, which are hormone-like substances that cause pain and inflammation.
Phennin (phenyl acetylsalicylate) is a small molecule drug with unknown target and drug class. Its commercial status is unclear, and it is not known whether it is FDA approved or off-patent. The approved indications for Phennin are also unknown. Further research is needed to determine its key safety considerations and pharmacokinetic properties. As a result, Phennin remains a relatively understudied compound.
At a glance
| Generic name | phenyl acetylsalicylate |
|---|---|
| Therapeutic area | Pain |
| Phase | unknown |
Mechanism of action
Think of prostaglandins like messengers that tell your body to feel pain and become inflamed. Phennin blocks these messengers, which helps to reduce pain and inflammation. This is similar to how aspirin works, but Phennin is a different molecule with potentially different effects.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Phennin CI brief — competitive landscape report
- Phennin updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Phennin
What is Phennin?
How does Phennin work?
What is the generic name of Phennin?
What development phase is Phennin in?
Related
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Pain
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing